G. Contant

952 total citations
31 papers, 755 citations indexed

About

G. Contant is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Hematology. According to data from OpenAlex, G. Contant has authored 31 papers receiving a total of 755 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 9 papers in Internal Medicine and 8 papers in Hematology. Recurrent topics in G. Contant's work include Atrial Fibrillation Management and Outcomes (9 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). G. Contant is often cited by papers focused on Atrial Fibrillation Management and Outcomes (9 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). G. Contant collaborates with scholars based in France, United States and Germany. G. Contant's co-authors include J.L. Martinoli, Y Gourmelin, M Samama, Elisabeth Perzborn, Léna Le Flem, Céline Guinet, Theodore E. Spiro, M Gouault-Heilmann, Gabriele Rohde and Y. Huet and has published in prestigious journals such as Blood, Arteriosclerosis Thrombosis and Vascular Biology and Anesthesiology.

In The Last Decade

G. Contant

29 papers receiving 718 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Contant France 14 467 423 192 143 58 31 755
Léna Le Flem France 10 571 1.2× 530 1.3× 173 0.9× 106 0.7× 46 0.8× 20 779
Rosemarie Reiter Austria 10 151 0.3× 72 0.2× 231 1.2× 75 0.5× 114 2.0× 13 522
Cafer Adıgüzel United States 12 186 0.4× 180 0.4× 80 0.4× 99 0.7× 26 0.4× 40 466
James M. Stengle United States 9 147 0.3× 202 0.5× 54 0.3× 62 0.4× 105 1.8× 16 498
Edmond R. Cole United States 10 161 0.3× 96 0.2× 257 1.3× 156 1.1× 23 0.4× 27 528
Clara V. Hussey United States 14 72 0.2× 106 0.3× 287 1.5× 134 0.9× 23 0.4× 45 570
Charlotte Grosdidier France 9 224 0.5× 80 0.2× 107 0.6× 134 0.9× 42 0.7× 16 461
Mengduan Liu China 7 69 0.1× 68 0.2× 90 0.5× 72 0.5× 66 1.1× 22 588
Paul M. Allison United States 12 78 0.2× 22 0.1× 74 0.4× 107 0.7× 17 0.3× 20 405
Ye Chao United States 4 328 0.7× 16 0.0× 144 0.8× 81 0.6× 191 3.3× 5 663

Countries citing papers authored by G. Contant

Since Specialization
Citations

This map shows the geographic impact of G. Contant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Contant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Contant more than expected).

Fields of papers citing papers by G. Contant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Contant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Contant. The network helps show where G. Contant may publish in the future.

Co-authorship network of co-authors of G. Contant

This figure shows the co-authorship network connecting the top 25 collaborators of G. Contant. A scholar is included among the top collaborators of G. Contant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Contant. G. Contant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Repessé, Yohann, et al.. (2025). Chondroitin Sulfate as a New Profibrinolytic-Like Agent: A Preclinical Proof of Concept in a Model of Thromboembolic Stroke in Mice. Arteriosclerosis Thrombosis and Vascular Biology. 46(1). 178–192.
2.
Soria, J, et al.. (2024). Blood Clot Dynamics and Fibrinolysis Impairment in Cancer: The Role of Plasma Histones and DNA. Cancers. 16(5). 928–928. 1 indexed citations
3.
Helms, Julie, Anaïs Curtiaud, François Séverac, et al.. (2024). Fibrinolysis as a Causative Mechanism for Bleeding Complications on Extracorporeal Membrane Oxygenation: A Pilot Observational Prospective Study. Anesthesiology. 141(1). 75–86. 13 indexed citations
4.
Contant, G., Mikaël Mazighi, Bertrand Montpellier, et al.. (2023). Assessment of inter‐operator variability in peripheral monocyte subset gating strategy using flow cytometry in patients with suspected acute stroke. Cytometry Part A. 105(3). 171–180.
5.
Mathieu, Olivier, et al.. (2021). Measuring residual anti‐Xa activity of direct factor Xa inhibitors after reversal with andexanet alfa. International Journal of Laboratory Hematology. 43(4). 795–801. 15 indexed citations
6.
Depasse, François, et al.. (2020). Evaluation of DOAC Filter, a new device to remove direct oral anticoagulants from plasma samples. International Journal of Laboratory Hematology. 42(5). 636–642. 20 indexed citations
7.
Shah, Shahid, G. Contant, Réa Lo Dico, et al.. (2018). The close relationship between heparanase and epithelial mesenchymal transition in gastric signet-ring cell adenocarcinoma. Oncotarget. 9(73). 33778–33787. 14 indexed citations
8.
Soria, J.C., et al.. (2017). The close relationship between heparanase and epithelial mesenchymal transition related fibrosis in gastric signet-ring cell adenocarcinoma. European Journal of Cancer. 72. S79–S79. 2 indexed citations
9.
10.
Samama, M, G. Contant, Theodore E. Spiro, et al.. (2013). Laboratory assessment of rivaroxaban: a review. Thrombosis Journal. 11(1). 11–11. 126 indexed citations
11.
Samama, M, G. Contant, Theodore E. Spiro, et al.. (2012). Anti-Factor Xa chromogenic assay for measuring rivaroxaban plasma concentrations using calibrators and controls: results of a multicentre field trial. 1 indexed citations
12.
Samama, M, G. Contant, Theodore E. Spiro, et al.. (2012). Evaluation of the Prothrombin Time for Measuring Rivaroxaban Plasma Concentrations Using Calibrators and Controls. Clinical and Applied Thrombosis/Hemostasis. 18(2). 150–158. 73 indexed citations
13.
Samama, M, G. Contant, Theodore E. Spiro, et al.. (2012). Evaluation of the antifactor XA chromogenic assay for measuring rivaroxaban plasma concentrations using calibrators and controls. European Journal of Hospital Pharmacy. 19(2). 236.3–237. 5 indexed citations
14.
Contant, G., Theodore E. Spiro, Elisabeth Perzborn, et al.. (2011). Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls. Thrombosis and Haemostasis. 107(2). 379–387. 201 indexed citations
15.
Contant, G., et al.. (1999). A new gel tube method for the direct detection, identification and susceptibility testing of bacteria in clinical samples. FEMS Microbiology Letters. 170(1). 229–235. 1 indexed citations
16.
Contant, G., et al.. (1999). [A chromogenic method for rapid identification of Staphylococcus aureus].. PubMed. 57(2). 191–6. 5 indexed citations
17.
Boyer‐Neumann, Catherine, Catherine Leroy‐Matheron, J.L. Martinoli, et al.. (1991). Functional assay of protein S in 70 patients with congenital and acquired disorders. Blood Coagulation & Fibrinolysis. 2(6). 705–712. 20 indexed citations
18.
Contant, G., et al.. (1989). Determination of plasminogen activator inhibitor (PAI) activity of human plasma after dilution in a PAI-depleted plasma. Thrombosis Research. 56(3). 377–386. 2 indexed citations
19.
Amiral, Jean, et al.. (1988). Measurement of tPA and tPA - PAI-1 complexes by Elisa, using monoclonal antibodies: Clinical relevance. Thrombosis Research. 49. 99–113. 29 indexed citations
20.
Gouault-Heilmann, M, Y. Huet, Serge Adnot, et al.. (1987). Low Molecular Weight Heparin Fractions as an Alternative Therapy in Heparin-induced Thrombocytopenia. Pathophysiology of Haemostasis and Thrombosis. 17(3). 134–140. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Léna Le Flem Breakdown of academic impact, for papers by Rosemarie Reiter Breakdown of academic impact, for papers by Cafer Adıgüzel Breakdown of academic impact, for papers by James M. Stengle Breakdown of academic impact, for papers by Edmond R. Cole Breakdown of academic impact, for papers by Clara V. Hussey Breakdown of academic impact, for papers by Charlotte Grosdidier Breakdown of academic impact, for papers by Mengduan Liu Breakdown of academic impact, for papers by Paul M. Allison Breakdown of academic impact, for papers by Ye Chao
Rankless by CCL
2026